Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Finasteride effectively treats male hair loss, improving growth and density.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Women with high androgen levels may have more severe COVID-19 symptoms.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

A new hair treatment with caffeine and other ingredients makes hair thicker and less likely to break.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

New compounds were found to help increase hair growth and decrease hair loss.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.